$ISDR
ISSUER DIRECT CORP Stock $isdr

$isdr Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000165495423006241 Filed on May 11, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$9.651M	$8.619M	$5.288M
YoY Change	66.2%	62.99%	6.18%
Cost Of Revenue	$2.336M	$1.829M	$1.232M
YoY Change	71.26%	48.46%	-11.62%
Gross Profit	$7.315M	$6.790M	$4.056M
YoY Change	64.64%	67.41%	13.11%
Gross Profit Margin	75.8%	78.78%	76.7%
Selling, General & Admin	$4.313M	$4.713M	$2.947M
YoY Change	47.0%	59.93%	18.93%
% of Gross Profit	58.96%	69.41%	72.66%
Research & Development	$532.0K	$774.0K	$275.0K
YoY Change	148.6%	181.45%	10.44%
% of Gross Profit	7.27%	11.4%	6.78%
Depreciation & Amortization	$736.0K	$736.0K	$162.0K
YoY Change	354.32%	354.32%	-43.16%
% of Gross Profit	10.06%	10.84%	3.99%
Operating Expenses	$5.568M	$6.209M	$3.368M
YoY Change	68.98%	84.35%	16.99%
Operating Profit	$1.747M	$581.0K	$688.0K
YoY Change	52.18%	-15.55%	-2.69%
Interest Expense	-$281.0K	-$238.0K	$2.000K
YoY Change	-1505.0%	-12000.0%	100.0%
% of Operating Profit	-16.08%	-40.96%	0.29%
Other Income/Expense, Net	$379.0K	$535.0K	$0.00
YoY Change
Pretax Income	$1.845M	-$192.0K	$690.0K
YoY Change	57.96%	-127.83%	-2.54%
Income Tax	$482.0K	-$48.00K	$174.0K
% Of Pretax Income	26.12%		25.22%
Net Earnings	$1.363M	-$144.0K	$516.0K
YoY Change	62.07%	-127.91%	-5.32%
Net Earnings / Revenue	14.12%	-1.67%	9.76%
Basic Earnings Per Share	$0.36	-$0.04	$0.14
Diluted Earnings Per Share	$0.36	-$0.04	$0.13
COMMON SHARES
Basic Shares Outstanding	3.791M shares	3.791M shares	3.794K shares
Diluted Shares Outstanding	3.808K shares	3.810M shares	3.834K shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.961M	$3.349M	$24.27M
YoY Change	-76.88%	-86.2%	18.12%
Cash & Equivalents	$4.961M	$3.349M	$24.27M
Short-Term Investments
Other Short-Term Assets	$1.597M	$1.416M	$879.0K
YoY Change	88.55%	61.09%	129.5%
Inventory
Prepaid Expenses
Receivables	$4.311M	$3.546M	$3.950M
Other Receivables	$0.00	$139.0K	$0.00
Total Short-Term Assets	$10.87M	$8.450M	$29.10M
YoY Change	-58.3%	-70.96%	21.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$563.0K	$594.0K	$696.0K
YoY Change	-16.47%	-14.66%	-10.19%
Goodwill	$22.50M	$16.12M	$6.376M
YoY Change	252.85%	152.85%	0.0%
Intangibles	$30.86M	$59.05M	$2.339M
YoY Change	1283.24%	2424.37%	-16.13%
Long-Term Investments
YoY Change
Other Assets	$397.0K	$176.0K	$83.00K
YoY Change	336.26%	112.05%	-10.75%
Total Long-Term Assets	$55.75M	$56.15M	$11.15M
YoY Change	409.23%	403.67%	-8.5%
TOTAL ASSETS
Total Short-Term Assets	$10.87M	$8.450M	$29.10M
Total Long-Term Assets	$55.75M	$56.15M	$11.15M
Total Assets	$66.61M	$64.60M	$40.25M
YoY Change	79.98%	60.5%	11.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.286M	$1.560M	$850.0K
YoY Change	120.21%	83.53%	44.31%
Accrued Expenses	$2.374M	$2.344M	$1.791M
YoY Change	36.52%	30.88%	-14.63%
Deferred Revenue
YoY Change
Short-Term Debt	$2.000M	$1.000M	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$12.08M	$10.24M	$6.324M
YoY Change	99.8%	61.92%	16.51%
LONG-TERM LIABILITIES
Long-Term Debt	$17.90M	$18.92M	$0.00
YoY Change
Other Long-Term Liabilities	$1.175M	$165.0K	$1.580M
YoY Change	-21.72%	-89.56%	-16.4%
Total Long-Term Liabilities	$17.90M	$19.09M	$1.580M
YoY Change	1092.8%	1107.91%	-16.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.08M	$10.24M	$6.324M
Total Long-Term Liabilities	$17.90M	$19.09M	$1.580M
Total Liabilities	$31.44M	$31.18M	$8.045M
YoY Change	310.28%	287.59%	6.13%
SHAREHOLDERS EQUITY
Retained Earnings	$12.39M	$11.02M	$9.750M
YoY Change	16.96%	13.07%	50.28%
Common Stock	$4.000K	$4.000K	$4.000K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$35.18M	$33.42M	$32.20M
YoY Change
Total Liabilities & Shareholders Equity	$66.61M	$64.60M	$40.25M
YoY Change	79.98%	60.5%	11.55%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	$1.363M	-$144.0K	$516.0K
YoY Change	62.07%	-127.91%	-5.32%
Depreciation, Depletion And Amortization	$736.0K	$736.0K	$162.0K
YoY Change	354.32%	354.32%	-43.16%
Cash From Operating Activities	$1.731M	$272.0K	$548.0K
YoY Change	57.94%	-50.36%	-56.82%
INVESTING ACTIVITIES
Capital Expenditures	$173.0K	$5.000K	-$21.00K
YoY Change	-1117.65%	-123.81%	-231.25%
Acquisitions		-$350.0K	$0.00
YoY Change
Other Investing Activities	$0.00	$350.0K
YoY Change
Cash From Investing Activities	-$173.0K	$345.0K	-$21.00K
YoY Change	917.65%	-1742.86%	31.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$22.00M
YoY Change
Cash From Financing Activities	0.000	-$2.100M	-124.0K
YoY Change	-100.0%	1593.55%	-50.99%
NET CHANGE
Cash From Operating Activities	1.731M	$272.0K	$548.0K
Cash From Investing Activities	-173.0K	$345.0K	-21.00K
Cash From Financing Activities	0.000	-$2.100M	-124.0K
Net Change In Cash	1.558M	-$1.483M	$548.0K
YoY Change	-156.04%	-370.62%	-45.2%
FREE CASH FLOW
Cash From Operating Activities	$1.731M	$272.0K	$548.0K
Capital Expenditures	$173.0K	$5.000K	-$21.00K
Free Cash Flow	$1.558M	$267.0K	$569.0K
YoY Change	39.98%	-53.08%	-54.59%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	22880000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	370000	usd
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000843006
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3791020	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3791020	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3791020	shares
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	179845	shares
CY2021Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	179845	shares
CY2022Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ISSUER DIRECT CORPORATION
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity File Number EntityFileNumber	1-10185
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1331503
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Glenwood Avenue
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1001
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Raleigh
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NC
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	27603
CY2023Q1	dei	City Area Code CityAreaCode	919
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	481-4000
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3791020	shares
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001
CY2023Q1	dei	Trading Symbol TradingSymbol	ISDR
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3349000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4832000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	858000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	745000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	3546000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2978000	usd
CY2023Q1	us-gaap	Income Tax Receivable IncomeTaxReceivable	139000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	51000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1416000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1559000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	8450000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9420000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3379000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	3364000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	123000	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	138000	usd
CY2023Q1	us-gaap	Flight Equipment Accumulated Depreciation FlightEquipmentAccumulatedDepreciation	646000	usd
CY2022Q4	us-gaap	Flight Equipment Accumulated Depreciation FlightEquipmentAccumulatedDepreciation	610000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	594000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	625000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1213000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1277000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	176000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	136000	usd
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	22498000	usd
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	22498000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7507000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6821000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	31545000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32231000	usd
CY2023Q1	us-gaap	Assets Assets	64599000	usd
CY2022Q4	us-gaap	Assets Assets	66325000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1560000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1374000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2344000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2255000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	170000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	157000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1000000	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	22000000	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5166000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5405000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10240000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31191000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	80000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	18920000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q1	isdr	Deferred Tax Liability Noncurrent DeferredTaxLiabilityNoncurrent	599000	usd
CY2022Q4	isdr	Deferred Tax Liability Noncurrent DeferredTaxLiabilityNoncurrent	572000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1258000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1339000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	165000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	usd
CY2023Q1	us-gaap	Liabilities Liabilities	31182000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	33102000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3791020	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22484000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22147000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-95000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-96000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11024000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11168000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	33417000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	33223000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	64599000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	66325000	usd
CY2023Q1	us-gaap	Revenues Revenues	8619000	usd
CY2022Q1	us-gaap	Revenues Revenues	5288000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1829000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	1232000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	6790000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	4056000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2332000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1683000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2381000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1264000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	774000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	275000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	722000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	146000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	6209000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	3368000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	581000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	688000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-238000	usd
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2000	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	535000	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	0	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-192000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	690000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-48000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	174000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	516000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3791000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3794000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3810000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3834000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-144000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	516000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	7000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-143000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	523000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	31620000	usd
CY2022Q1	isdr	Stock Based Compensation Expense StockBasedCompensationExpense	184000	usd
CY2022Q1	isdr	Exercise Of Stock Awards Net Of Tax Amount ExerciseOfStockAwardsNetOfTaxAmount	58000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-182000	usd
CY2022Q1	isdr	Foreign Currency Translation ForeignCurrencyTranslation	7000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	516000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	32203000	usd
CY2023Q1	isdr	Stock Based Compensation Expense StockBasedCompensationExpense	337000	usd
CY2023Q1	isdr	Foreign Currency Translation ForeignCurrencyTranslation	1000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	33417000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-144000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	516000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	736000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	162000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	151000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	101000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	26000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-35000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	337000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	184000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	719000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	752000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	250000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	55000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	186000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	154000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	187000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-53000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-238000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	326000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	272000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	548000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-350000	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	21000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	345000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	58000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	182000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	22000000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	19968000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	68000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2100000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-124000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1483000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	403000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4832000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23852000	usd
CY2023Q1	isdr	Effect Of Exchange Rates On Cash EffectOfExchangeRatesOnCash	0	usd
CY2022Q1	isdr	Effect Of Exchange Rates On Cash EffectOfExchangeRatesOnCash	16000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3349000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24271000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023Q1	us-gaap	Interest Paid InterestPaid	510000	usd
CY2022Q1	us-gaap	Interest Paid InterestPaid	0	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	74250	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	50250	shares
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	5166000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	5405000	usd
CY2023Q1	isdr	Revenue Recognized Included In The Deferred Revenue RevenueRecognizedIncludedInTheDeferredRevenue	2557000	usd
CY2022	isdr	Revenue Recognized Included In The Deferred Revenue RevenueRecognizedIncludedInTheDeferredRevenue	1391000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	3546000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	2978000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	125000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	105000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	745000	usd
CY2023Q1	us-gaap	Interest And Debt Expense InterestAndDebtExpense	151000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	38000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	858000	usd
CY2023Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">Financial instruments and related items which potentially subject the Company to concentrations of credit risk consist primarily of cash, cash equivalents and accounts receivables. The Company places its cash and temporary cash investments with credit quality institutions. Such cash balances are currently in excess of the FDIC insurance limit of $250,000. To reduce its risk associated with the failure of such financial institutions, each quarter the Company evaluates the rating of each financial institution in which it holds deposits. As of March 31, 2023, the total amount exceeding such limit was $1,074,000. The Company also had cash-on-hand of $32,000 in Europe and $1,569,000 in Canada as of March 31, 2023.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The Company believes it did not have any financial instruments that could have potentially subjected us to significant concentrations of credit risk for any relevant period.</p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	1074000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 0.5in; text-align:justify;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include the allowance for doubtful accounts and the valuation of goodwill, intangible assets, deferred tax assets, and stock-based compensation. Actual results could differ from those estimates.</p>
CY2023Q1	isdr	Amortization Included In Cost Of Revenues AmortizationIncludedInCostOfRevenues	15000	usd
CY2022Q1	isdr	Amortization Included In Cost Of Revenues AmortizationIncludedInCostOfRevenues	16000	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	462000	usd
CY2022Q1	us-gaap	Advertising Expense AdvertisingExpense	95000	usd
CY2023Q1	isdr	Summary Of The Fair Value Consideration Transferred For The Acquisition SummaryOfTheFairValueConsiderationTransferredForTheAcquisition	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Consideration transferred:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash payment</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">18,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Secured promissory note</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">22,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Shares of Issuer Direct common stock based on closing market price prior to the Acquisition</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,892</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net working capital adjustment and other costs paid on behalf of Seller, net of cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(350 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total consideration transferred </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">43,542</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Preliminary allocation of tangible and intangible assets and liabilities:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Goodwill</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">16,122</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Trademarks/Tradename</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">27,500</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Technology</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,520</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Customer relationships</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">580</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net liabilities assumed</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(3,180 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total amount allocated</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">43,542</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Net liabilities assumed:</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">37</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts Receivable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">90</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Other Current Assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accounts Payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(645 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Accrued Expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(226 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred Revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,775 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Deferred tax liability</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(675 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(3,180 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr></tbody></table>
CY2023Q1	us-gaap	Goodwill Goodwill	16122000	usd
CY2023Q1	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	27500000	usd
CY2023Q1	isdr	Technology Technology	2520000	usd
CY2023Q1	us-gaap	Finite Lived Customer Relationships Gross FiniteLivedCustomerRelationshipsGross	580000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	3180000	usd
CY2023Q1	us-gaap	Goodwill Not Allocated Amount GoodwillNotAllocatedAmount	43542000	usd
CY2023Q1	isdr	Schedule Of Of The Results Of Operations ScheduleOfOfTheResultsOfOperations	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>in $000’s, except per share amounts</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>March 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Revenues</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">8,750</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">665</td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Basic earnings per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.17</td><td style="width:1%;white-space: nowrap;"/></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Diluted earnings per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.17</td><td style="width:1%;white-space: nowrap;"/></tr></tbody></table>
CY2023Q1	isdr	Stock Repurchased And Retired During Period Shares1 StockRepurchasedAndRetiredDuringPeriodShares1	207964	shares
CY2023Q1	us-gaap	Accelerated Share Repurchases Final Price Paid Per Share AcceleratedShareRepurchasesFinalPricePaidPerShare	24.04
CY2023Q1	isdr	Stock Repurchased During Period Shares1 StockRepurchasedDuringPeriodShares1	207964	shares
CY2023Q1	isdr	Stock Repurchases Program Remaining Authorized Repurchase Amount1 StockRepurchasesProgramRemainingAuthorizedRepurchaseAmount1	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	111250	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M17D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.01
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	44500	shares
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	757000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2231000	usd
CY2023Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	48000	usd
CY2022Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	174000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	isdr	Operating Lease Liability Total OperatingLeaseLiabilityTotal	1629000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	371000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1258000	usd
CY2023Q1	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	440000	usd
CY2023Q1	isdr	Payment For Other Expenss PaymentForOtherExpenss	370000	usd
CY2023Q1	isdr	Termination Of Unsecured Line Of Credit TerminationOfUnsecuredLineOfCredit	3000000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	76000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	89000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	6000	usd
CY2022Q1	us-gaap	Variable Lease Cost VariableLeaseCost	18000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	82000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	107000	usd
CY2023Q1	isdr	Weighted Average Non Cancelable Lease Term WeightedAverageNonCancelableLeaseTerm	P4Y9M
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0377	pure
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	277000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo	380000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree	390000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour	401000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive	412000	usd
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths	1860000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	231000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1629000	usd
CY2023Q1	us-gaap	Revenues Revenues	8619000	usd
CY2023Q1	isdr	Concentration Risks Percentage1 ConcentrationRisksPercentage1	1.000	pure
CY2022Q1	us-gaap	Revenues Revenues	5288000	usd
CY2022Q1	isdr	Concentration Risks Percentage1 ConcentrationRisksPercentage1	1	pure
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	25000000	usd
CY2023Q1	isdr	Description Of Credit Agreement DescriptionOfCreditAgreement	(i) term loan facility in an aggregate principal amount of $20 million (the “Term Loan”), and (ii) revolving line of credit in an up to aggregate principal amount of $5 million (the “Revolving LOC”), subject to an 85% limit based on the current eligible accounts receivable (as defined in the Credit Agreement)
CY2023Q1	isdr	Description Of Credit Agreement DescriptionOfCreditAgreement	the per annum interest rate of the Term Loan is variable based on the one-month secured overnight financing rate (“SOFR”) plus 2.35%, subject to a minimum SOFR of 2.00%. However, the Term Loan issued on the Closing Date has a per annum interest rate of 6.217%, which was fixed with respect to the entire principal amount as a result of an interest rate swap agreement entered into between the Company and Pinnacle on the Closing Date in accordance with the terms of the Credit Agreement
CY2023Q1	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	333333	usd
CY2023Q1	isdr	Maturity Date MaturityDate	December 20, 2028
CY2023Q1	isdr	Interest Rate Swap Agreement InterestRateSwapAgreement	20000000	usd
CY2023Q1	isdr	Interest Rate Swap Agreemenrdescription InterestRateSwapAgreemenrdescription	the Company pays a fixed rate of interest at 6.217% and receives an average variable rate of SOFR + 2.35% adjusted monthly
CY2023Q1	isdr	Other Long Term Liability OtherLongTermLiability	165000	usd
CY2023Q1	isdr	Interest Rate Swap Loss In Other Expenses InterestRateSwapLossInOtherExpenses	165000	usd

Files In Submission

Name	View Source	Status
isdr-20230331_cal.xml	Edgar Link	unprocessable
isdr-20230331_pre.xml	Edgar Link	unprocessable
0001654954-23-006241-index-headers.html	Edgar Link	pending
0001654954-23-006241-index.html	Edgar Link	pending
0001654954-23-006241.txt	Edgar Link	pending
0001654954-23-006241-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
isdr-20230331.xsd	Edgar Link	pending
isdr_10q.htm	Edgar Link	pending
isdr_10qimg1.jpg	Edgar Link	pending
isdr_10qimg2.jpg	Edgar Link	pending
isdr_ex311.htm	Edgar Link	pending
isdr_ex312.htm	Edgar Link	pending
isdr_ex321.htm	Edgar Link	pending
isdr_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
isdr-20230331_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
isdr-20230331_lab.xml	Edgar Link	unprocessable
isdr_10q_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ISDR
ISSUER DIRECT CORP Stock $isdr

2023 Q2 Form 10-Q Financial Statement

#000165495423006241 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISDR ISSUER DIRECT CORP Stock $isdr

2023 Q2 Form 10-Q Financial Statement

#000165495423006241 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISDR
ISSUER DIRECT CORP Stock $isdr